Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2023

Sep 12, 2023

60507_rns_2023-09-12_f6a96c60-cafc-406f-b3a3-3dc9e0b35079.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

September 12, 2023

The Corporate Relationship Dept. The Manager, Listing Dept.
BSE Limited The National Stock Exchange of India Ltd.
1st Floor, P.J.Towers Exchange Plaza, 5th Floor,
Plot No. C/1,
Dalal Street, Fort G Block
Bandra-Kurla Complex, Bandra (E)
Mumbai – 400 001 Mumbai – 400 051
Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of resignation of Executive Director – Legal

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('SEBI Listing Regulations') the Company hereby wishes to inform that Mr. Samir Kazi, Executive Director – Legal has vide his letter dated September 11, 2023 has tendered his resignation from the employment of the Company to pursue an opportunity outside Pfizer Limited.

Consequently, Mr. Samir Kazi has resigned as a Director from the Board of Directors of the Company, with effect from the close of business on September 12, 2023. Pursuant to the above, Mr. Kazi shall cease to be a Member of the Corporate Social Responsibility Committee, Stakeholders' Relationship Committee and Board Administrative & Share Transfer Committee of the Board effective close of business on September 12, 2023. The effective date of resignation of Mr. Samir Kazi as an employee shall be from such date as may be mutually agreed between the Company and Mr. Kazi.

Further, the information required in terms of Regulation 30 read with Schedule Ill - Para A (7) of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No. SEBI/HO/CFD/ PoD2/CIR/P/2023/120 dated July 11, 2023 is enclosed as 'Annexure-I' to this letter.

Please find attached the letter of resignation received from Mr. Samir Kazi.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited PRAJEET NAIR

Digitally signed by PRAJEET NAIR Date: 2023.09.12 17:29:42 +05'30'

Director – Corporate Services & Company Secretary

Encl: A/a

Prajeet Nair

Annexure - I

Information as required under Regulation 30 read with Schedule III - Para A of Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Sr. No. Particulars Description
1. Reason for change viz. appointment,
resignation,
removal,
death
or
otherwise;
Resignation of Mr. Samir Kazi as
the
Executive Director – Legal and as a
Director
with
effect
from
close
of
business on
September 12, 2023
and as a
Senior Management Personnel of the
Company, effective such date
as may be
mutually agreed between the Company
and Mr. Kazi, to pursue an opportunity
outside Pfizer.
2. Date of appointment /
cessation (as
applicable) & term of appointment.
Cessation as the Executive Director –
Legal and as a Director effective close of
business on
September 12, 2023
and
as a
Senior Management Personnel
of the
Company effective such date as may be
mutually agreed between the Company
and Mr. Kazi.
3. Brief profile (in case of appointment) Not Applicable
4. Disclosure of relationships between
directors (in case of appointment of a
director).
Not Applicable

September 11, 2023

To,

The Board of Directors

Pfizer Limited The Capital, 1802/1901, Plot no. C-70, G-Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Dear Chairman Sir & Hon'ble Board of Directors,

Subject: Resignation as Executive Director - Legal of the Company

This is to inform you that I hereby tender my resignation from the employment of the Company to pursue an opportunity outside Pfizer Limited. Consequently, I hereby resign as a Director from the Board of Directors of the Company with effect from the close of business on September 12, 2023.

The effective date of my resignation as an employee of the Company shall be from such date as may be mutually agreed with the Company.

I thank you all for the guidance and support provided to me during my tenure as Executive Director - Legal and I wish the Company success in times to come.